Whitehawk Therapeutics Investor Relations Material
Latest events
Fireside Chat
Whitehawk Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Whitehawk Therapeutics Inc.
Access all reports
Aadi Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers and other serious diseases. The company's lead product is designed to target specific mutations in the mTOR pathway, a key regulator of cell growth and survival. The company is headquartered in Pacific Palisades, California, and its shares are listed on the NASDAQ.
Key slides for Whitehawk Therapeutics Inc.
Investor Update
Whitehawk Therapeutics Inc.
Q1 2025
Whitehawk Therapeutics Inc.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
WHWK
Country
🇺🇸 United States